Another year done and dusted. Closing 13.5% above 30 June 2022, or a 15.78% increase in valuation (adjusted for the increase in shares). Tax loss selling done too. If tax loss sellers last year just held firm instead, they'd be doing okay.
For context, the increase is better than your savings interest, more than covers increase in mortgage interest rate, and inflation, and in line with the ASX 200 index.
It is a mild increase in valuation / SP when you think about all that the company has achieved over the last 12 months, and all the hard preparatory work they have done (including on initiatives we may not have heard about yet) that will result in further milestones being achieved.
I'm looking forward to what the year ahead brings for us long term shareholders, as we bring online CPT CAT III code tomorrow.
Best wishes to us all!
- Forums
- ASX - By Stock
- 4DX
- Research
Research, page-1764
-
- There are more pages in this discussion • 976 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 4DX (ASX) to my watchlist
|
|||||
Last
44.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $182.6M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1356 | 45.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
44.0¢ | 112 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 12208 | 0.445 |
5 | 56490 | 0.440 |
1 | 5642 | 0.435 |
3 | 6300 | 0.430 |
3 | 26964 | 0.425 |
Price($) | Vol. | No. |
---|---|---|
0.440 | 112 | 1 |
0.445 | 19082 | 3 |
0.450 | 89694 | 1 |
0.455 | 18962 | 1 |
0.460 | 12362 | 2 |
Last trade - 09.50am 13/08/2024 (20 minute delay) ? |
Featured News
4DX (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online